pazelliptine has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisagni, E; Chermann, JC; Lhoste, JM; Rivalle, C; Tambourin, P; Wendling, F | 1 |
| Bisagni, E; Chermann, JC; Ducrocq, C; Gruest, J; Lidereau, R; Montagnier, L; Rivalle, C | 1 |
| Gros, P; Pierre, A; Pierson, V; Pommier, Y | 1 |
3 other study(ies) available for pazelliptine and Leukemia L 1210
| Article | Year |
|---|---|
Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Survival; Drug Evaluation, Preclinical; Isoquinolines; Leukemia L1210; Mice; Pyridines; Structure-Activity Relationship | 1983 |
Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.
Topics: Animals; Antineoplastic Agents; Cell Division; Cricetinae; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ellipticines; Indoles; Isoquinolines; Leukemia L1210; Mice; Pyridines; Structure-Activity Relationship | 1980 |
Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Nucleus; Cell Survival; DNA; DNA Damage; DNA, Single-Stranded; Indoles; Intercalating Agents; Isoquinolines; Leukemia L1210; Proteins; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1988 |